Bringing Linaclotide to Patients Around the World
Ironwood has built the team and capabilities to deliver linaclotide to patients in the United States. But our goal is to get this medicine to appropriate patients around the world, in the most efficient way possible, and we’re committed to working with our network of partners both in the U.S. and in other countries to achieve that goal.
LINZESS®* available in U.S. through 50/50 collaboration
in certain European countries through partnership
Under review by regulatory authority
for potential approval
LINZESS® approved in Japan through partnership